Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.60
+0.10 (0.47%)
Sep 30, 2026, 4:08 PM HKT

HKG:2190 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
304.88244.37100.26-78.73-113.56-199.69
Depreciation & Amortization
40.4236.9136.9235.2326.2713.38
Other Amortization
10.720.930.65--
Loss (Gain) From Sale of Assets
0.090.090.050.599.13-0.02
Asset Writedown & Restructuring Costs
0.990.996.74---
Loss (Gain) From Sale of Investments
0.630.6336.258.53-4.78-13.93
Loss (Gain) on Equity Investments
--1.1---
Stock-Based Compensation
28.728.723.7485.7787.6876.21
Other Operating Activities
17.993.05-19.1113.63-23.525
Change in Accounts Receivable
-6.83-6.83-0.35-0.17-0.57-0.33
Change in Inventory
29.6529.65-38.93-47.3-61.97-28.28
Change in Accounts Payable
40.1740.1724.9436.3936.7644.55
Change in Other Net Operating Assets
6.426.421.5543.86-46.75-13.11
Operating Cash Flow
464.11384.86174.0898.44-91.32-116.21
Operating Cash Flow Growth
107.60%121.09%76.83%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-92.26-111.22-191.34-190.92-134.74-78.11
Sale of Property, Plant & Equipment
0.470.420.070.39-0.11
Sale (Purchase) of Intangibles
-----10.55-11.49
Investment in Securities
225.6262.06-617.81-24.3950.24-1,239
Other Investing Activities
-04.077.728.67--
Investing Cash Flow
-69.64-44.68-801.36-206.24-95.05-1,328

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1398750-5
Long-Term Debt Repaid
--169.5-54.58-6.41-4.89-39.2
Lease Payments
-5.03-3.5-4.58-6.41-4.89-4.2
Net Debt Issued (Repaid)
-8.62-30.532.4243.59-4.89-34.2
Issuance of Common Stock
9.329.810.06--2,968
Repurchase of Common Stock
-189.94-119.6-72.28-53.8-24.64-9.15
Common Dividends Paid
-73.39-32.69----
Other Financing Activities
-1.35-1.02-2.18-1.25-0.72-115.06
Financing Cash Flow
-263.97-174-41.98-11.46-30.262,810

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-15.89-4.740.790.543.57-6.46
Net Cash Flow
114.61161.45-668.47-118.72-213.061,359

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
371.85273.64-17.26-92.48-226.06-194.32
Free Cash Flow Growth
263.84%-----
Free Cash Flow Margin
30.79%25.88%-2.21%-17.52%-67.66%-109.22%
Free Cash Flow Per Share
1.160.85-0.05-0.28-0.68-0.66
Levered Free Cash Flow
115.53128.84-152.77-53.44-226.74-129.84
Unlevered Free Cash Flow
117.24129.48-151.41-52.65-226.29-129.65
Free Cash Flow After Leases
366.82270.15-21.84-98.89-230.95-198.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.351.022.181.250.720.31
Change in Working Capital
69.4169.41-12.7932.78-72.542.83